Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone
- PMID: 2416910
Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone
Abstract
In view of previous studies indicating that the irreversible properties of opiate azines such as naloxonazine are not due to a bivalent mechanism, we have synthesized a series of opiate hydrazones. In standard competition assays which measure both reversible and irreversible inhibition of binding, the hydrazone derivatives lowered radiolabeled opioid binding almost as well as naloxone and oxymorphone. However, the phenylhydrazone derivatives produced a profound wash-resistant inhibition of binding. The similar potencies of the methylhydrazine and phenylhydrazine derivatives in standard competition studies contrasted significantly with their effectiveness in eliciting wash-resistant inhibition of binding, suggesting the importance of the phenyl group in the production of wash-resistant inhibition. The p-nitrophenyl hydrazones were the most effective wash-irreversible inhibitors. Although oxymorphonazine does not irreversibly inhibit radiolabeled opioid binding as effectively as naloxonazine or naltrexonazine, the oxymorphone phenylhydrazones were as potent as their corresponding naloxone compounds. Incubation of [3H]naloxone-p-nitrophenylhydrazone with albumin demonstrated significant incorporation of radiolabel into the protein after sodium dodecylsulfate gel electrophoresis. This suggests that the phenylhydrazones have significant reactivities toward proteins and might produce their irreversible actions through covalent interactions.
Similar articles
-
Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.J Pharmacol Exp Ther. 1985 Dec;235(3):839-45. J Pharmacol Exp Ther. 1985. PMID: 2416909
-
Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.J Pharmacol Exp Ther. 1988 Apr;245(1):8-12. J Pharmacol Exp Ther. 1988. PMID: 2452249
-
Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines.J Neurosci. 1982 May;2(5):572-6. doi: 10.1523/JNEUROSCI.02-05-00572.1982. J Neurosci. 1982. PMID: 6176696 Free PMC article.
-
Structure-activity studies of narcotic agonists and antagonists from quantum chemical calculations.NIDA Res Monogr. 1978;(22):278-316. NIDA Res Monogr. 1978. PMID: 213725 Review.
-
Opioid receptors and their subtypes: focus on peripheral isolated tissue preparations.Neurochem Int. 1994 May;24(5):427-32. doi: 10.1016/0197-0186(94)90090-6. Neurochem Int. 1994. PMID: 7647697 Review. No abstract available.
Cited by
-
Mu opioids and their receptors: evolution of a concept.Pharmacol Rev. 2013 Sep 27;65(4):1257-317. doi: 10.1124/pr.112.007138. Print 2013. Pharmacol Rev. 2013. PMID: 24076545 Free PMC article. Review.
-
Naloxone-6 alpha-spirohydantoin: a long-acting opiate antagonist.Neurochem Res. 1989 Dec;14(12):1229-34. doi: 10.1007/BF00965514. Neurochem Res. 1989. PMID: 2560821
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources